“Pathologic Complete Response After Preoperative Ipilimumab and Nivolumab in an HLRCC Patient With Stage III RenalCell Carcinoma”. Journal of Kidney Cancer, vol. 13, no. 2, June 2026, pp. 21-28, https://doi.org/10.15586/jkcvhl.v13i2.455.